Association of Blastocystis subtype 3 with elevated IL-8–mediated inflammation in patients with irritable bowel syndrome
4 affiliations
- 1Department of Medical Parasitology, Faculty of Medicine, Cairo University
- 2Department of Pharmacology and Toxicology, Egyptian Drug Authority (EDA)
- 3Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine, Kafrelsheikh University
- 4Department of Human Physiology, Faculty of Medicine, Suez Canal University
Abstract
Background The role of Blastocystis in the pathophysiology of irritable bowel syndrome (IBS) remains controversial, with emerging evidence suggesting subtype-specific differences in pathogenicity. Interleukin-8 (IL-8), a key pro-inflammatory chemokine, has been implicated in mucosal immune activation in both IBS and parasitic infections. Objective This study aimed to investigate the association between Blastocystis subtypes and clinical manifestations of IBS, with a particular focus IL-8 as part of the systemic pro-inflammatory immune response associated with functional GIT disorders and intestinal infections. Methods In this cross-sectional study, 298 symptomatic patients attending a tertiary gastroenterology clinic were evaluated using Rome IV criteria for IBS diagnosis. Identification of Blastocystis in stool samples was done by direct microscopic examination. Subtype identification using PCR and subtype-specific sequence-tagged site primers were also performed. A balanced random selection was used to compare serum IL-8 levels between Blastocystis-positive IBS patients and an equal number of randomly selected Blastocystis-negative IBS patients. Clinical, biochemical, and demographic variables were analyzed in relation to infection status and subtype distribution. Results IBS was diagnosed in 197 out of 298 participants (66.1%), among whom 57 (28.9%) were positive for Blastocystis. Subtype analysis revealed a predominance of subtype (ST) 3 (86%), followed by ST1 (14%). Serum IL-8 levels were significantly higher in Blastocystis-infected IBS patients compared to non-infected controls (129.24 ± 56.28 vs. 26.28 ± 9.28 pg/mL, P < 0.001). Multivariate analysis identified younger age, diarrhea, and spring presentation as independent predictors of Blastocystis infection. Conclusions IBS is frequently associated with Blastocystis infection, particularly with subtype ST3. Serum levels of IL-8 are higher in Blastocystis-infected IBS patients as compared to uninfected ones. Statistical comparison between IL-8 levels in both subtype groups revealed no significant difference, despite the higher numerical values among the ST3 group. The potential aggravating effect of blastocystosis on IBS symptomatology and the relation between individual subtypes and the pro-inflammatory cytokine response require further mechanistic and longitudinal studies to clarify the causal relationship between Blastocystis subtypes and IBS pathogenesis. In addition, local inflammatory markers should be used to study local immune modulation and identify molecular effectors implicated in the pathogenesis of Blastocystis in IBS -infected patients.
Related
- High-Calorie Diet Aggravates Lipopolysaccharide-Induced Pulmonary Inflammation in Juvenile Mice: Association of Acetate-Mediated Macrophage Polarization with AMPK/YAP Signaling
- Association of elevated circulating iron with bone mineral density and bone turnover markers in postmenopausal Saudi women with and without osteoporosis
- Dual immune dysregulation in adolescent-onset schizophrenia: attenuated B cell trophic support and elevated IL-23/Th17 inflammation are diagnostic and clinical biomarkers
- Idiopathic pneumoperitoneum: two cases with possible association to elevated intraluminal pressure.
- Elevated Intraocular Pressure Facilitates T-Cell–Mediated Retinal Ganglion Cell Loss
BibTeX
@article{morsy2026association,
title = {{Association of Blastocystis subtype 3 with elevated IL-8–mediated inflammation in patients with irritable bowel syndrome}},
author = {Salwa M. Morsy and Magda S. A. Abdeltawab and Amal M. Mahfoz and Mahmoud A. Elkerdawy and Hanaa S. Sallam and Amira R. Ismail},
journal = {Gut Pathogens},
year = {2026},
month = oct,
doi = {10.1186/s13099-026-00887-5},
url = {https://doi.org/10.1186/s13099-026-00887-5},
note = {CC BY},
}
RIS
TY - JOUR
TI - Association of Blastocystis subtype 3 with elevated IL-8–mediated inflammation in patients with irritable bowel syndrome
AU - Salwa M. Morsy
AU - Magda S. A. Abdeltawab
AU - Amal M. Mahfoz
AU - Mahmoud A. Elkerdawy
AU - Hanaa S. Sallam
AU - Amira R. Ismail
PY - 2026
DA - 2026/10/25
JO - Gut Pathogens
DO - 10.1186/s13099-026-00887-5
UR - https://doi.org/10.1186/s13099-026-00887-5
AB - Background The role of Blastocystis in the pathophysiology of irritable bowel syndrome (IBS) remains controversial, with emerging evidence suggesting subtype-specific differences in pathogenicity. Interleukin-8 (IL-8), a key pro-inflammatory chemokine, has been implicated in mucosal immune activation in both IBS and parasitic infections. Objective This study aimed to investigate the association between Blastocystis subtypes and clinical manifestations of IBS, with a particular focus IL-8 as part of the systemic pro-inflammatory immune response associated with functional GIT disorders and intestinal infections. Methods In this cross-sectional study, 298 symptomatic patients attending a tertiary gastroenterology clinic were evaluated using Rome IV criteria for IBS diagnosis. Identification of Blastocystis in stool samples was done by direct microscopic examination. Subtype identification using PCR and subtype-specific sequence-tagged site primers were also performed. A balanced random selection was used to compare serum IL-8 levels between Blastocystis-positive IBS patients and an equal number of randomly selected Blastocystis-negative IBS patients. Clinical, biochemical, and demographic variables were analyzed in relation to infection status and subtype distribution. Results IBS was diagnosed in 197 out of 298 participants (66.1%), among whom 57 (28.9%) were positive for Blastocystis. Subtype analysis revealed a predominance of subtype (ST) 3 (86%), followed by ST1 (14%). Serum IL-8 levels were significantly higher in Blastocystis-infected IBS patients compared to non-infected controls (129.24 ± 56.28 vs. 26.28 ± 9.28 pg/mL, P < 0.001). Multivariate analysis identified younger age, diarrhea, and spring presentation as independent predictors of Blastocystis infection. Conclusions IBS is frequently associated with Blastocystis infection, particularly with subtype ST3. Serum levels of IL-8 are higher in Blastocystis-infected IBS patients as compared to uninfected ones. Statistical comparison between IL-8 levels in both subtype groups revealed no significant difference, despite the higher numerical values among the ST3 group. The potential aggravating effect of blastocystosis on IBS symptomatology and the relation between individual subtypes and the pro-inflammatory cytokine response require further mechanistic and longitudinal studies to clarify the causal relationship between Blastocystis subtypes and IBS pathogenesis. In addition, local inflammatory markers should be used to study local immune modulation and identify molecular effectors implicated in the pathogenesis of Blastocystis in IBS -infected patients.
SN - 1757-4749
ER -